Pharmacokinetics and safety of propiverine in patients with fatty liver disease

M. Siepmann,A. Nokhodian,D. Thümmler,Wilhelm Kirch

Pharmacokinetics and safety of propiverine in patients with fatty liver disease

1998

M. Siepmann
A. Nokhodian
D. Thümmler
Wilhelm Kirch

Objective: The present study was designed to assess the pharmacokinetics of propiverine after single and multiple dosing in patients with and without fatty liver disease.

Keywords:

Diabetes mellitus
Dosing
Fatty liver
Oral administration
Medicine
Pharmacology
Propiverine
Adverse effect
Pharmacokinetics
Toxicity
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations